Likewise, insulin plus metformin treatment augmented cEPCs levels (CD34+CD133+KDR+) and improved functionality in T2DM patients in a major extend that metformin mono-treatment [171]. The gene discussed is CD34; the disease is type 2 diabetes mellitus.